Barchart on MSN

This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?

Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...

Tylenol’s maker pushes back against proposed label change linking pain reliever’s use in pregnancy to autism

The push for a label change came after President Donald Trump held a news conference last month in which he told pregnant ...

Kenvue urges FDA to reject request for autism warning on Tylenol

Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...
The Daily Cardinal

The Tylenol Crisis and RFK Jr.’s weaponization of science

Trump and RFK Jr.’s claims linking Tylenol to autism are false, spread fear, and undermine trust in public health. This ...
Barchart on MSN

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...

Tylenol’s maker pushes back against proposed label change linking pain reliever to autism

Kenvue, the American company that makes Tylenol, says the U.S. Food and Drug Administration should not make proposed changes ...
The News International

AI's flattery could spread false medical claims, study warns

A new study has revealed that the technology behind the Artificial Intelligence chatbots like ChatGPT, called large language ...
The Times of Northwest Indiana

Trump's unfounded claims heap new stress on household brand name Tylenol

Kennedy reups unproven Tylenol-autism link during Cabinet meeting as Trump repeats 'don't take it'. Trump suggests calling off Xi meeting after blasting China for restricting rare earths exports. What ...